Clinical trialNCT06572384RecruitingPhase 3Interventional

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

SponsorGlaxoSmithKlineEnrollment440Lung Diseases, Interstitial

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

GSK Clinical Trials
GlaxoSmithKline
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

131 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Gsk Investigational Site
Buenos Aires, Argentina
Alejandro Brigante
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Jose Maria Malet Ruiz
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
carolina mariasch
Recruiting
Gsk Investigational Site
Ciudad Autonoma Buenos Aires, Argentina
Maria Jose Lopez Meiller
Recruiting
Gsk Investigational Site
Córdoba, Argentina
Mercedes Cordoba
Recruiting
Gsk Investigational Site
Mendoza, Argentina
Carlos Martin Elias Rein
Recruiting
Gsk Investigational Site
Rosario, Argentina
Rodolfo Navarrete
Recruiting
Gsk Investigational Site
San Miguel de Tucumán, Argentina
Hector Raul Sueldo
Recruiting
Gsk Investigational Site
Santa Fe, Argentina
Nadia Benzaquen
Recruiting

Australia

Gsk Investigational Site
Adelaide, South Australia, Australia
Vidya Limaye
Recruiting
Gsk Investigational Site
Woodville, South Australia, Australia
Maureen Rischmueller
Recruiting
Gsk Investigational Site
Spearwood, Western Australia, Australia
Peter Bremner
Recruiting

Belgium

Gsk Investigational Site
Brussels, Belgium
Antoine Froidure
Recruiting
Gsk Investigational Site
Brussels, Belgium
Karin Melsens
Recruiting
Gsk Investigational Site
Liège, Belgium
Julien Guiot
Recruiting
Gsk Investigational Site
Namur, Belgium
Caroline Dahlqvist
Recruiting

Brazil

Gsk Investigational Site
Barra Mansa, Brazil
Gilmar Alves Zonzin
Recruiting
Gsk Investigational Site
Juiz de Fora, Brazil
Viviane Souza
Recruiting
Gsk Investigational Site
Porto Alegre, Brazil
Adalberto Rubin
Recruiting
Gsk Investigational Site
Porto Alegre, Brazil
Mauro Keiserman
Recruiting
Gsk Investigational Site
São José do Rio Preto, Brazil
Philippe Colares
Recruiting
Gsk Investigational Site
São Paulo, Brazil
Ana Paula Assad
Recruiting
Gsk Investigational Site
São Paulo, Brazil
Bruno Baldi
Recruiting

Canada

Gsk Investigational Site
Montreal, Quebec, Canada
Andrew Hirsch
Recruiting
Gsk Investigational Site
Trois-Rivières, Quebec, Canada
Patrice Gauthier
Recruiting

China

Gsk Investigational Site
Beijing, China
Mengtao Li
Recruiting
Gsk Investigational Site
Beijing, China
Juan Meng
Recruiting
Gsk Investigational Site
Chengdu, China
wubin long
Recruiting
Gsk Investigational Site
Guangzhou, China
Yang Li
Recruiting
Gsk Investigational Site
Guangzhou, China
Yunfeng Pan
Recruiting
Gsk Investigational Site
Hangzhou, China
Jing Xue
Recruiting
Gsk Investigational Site
Hangzhou, China
Jin Lin
Recruiting
Gsk Investigational Site
Mianyang, China
Jing Yang
Recruiting
Gsk Investigational Site
Nanjing, China
Lingyun Sun
Recruiting
Gsk Investigational Site
Nanjing, China
Wenfeng Tan
Recruiting
Gsk Investigational Site
Nanning, China
jinying lin
Recruiting
Gsk Investigational Site
Shanghai, China
LI TING
Recruiting
Gsk Investigational Site
Shanghai, China
Weiguo Wan
Recruiting
Gsk Investigational Site
Shenyang, China
Rong Zhang
Recruiting
Gsk Investigational Site
Suzhou, China
Jian wu
Recruiting

91 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 Sept 2024
Primary completion: 18 Oct 2028
Completion: 13 Dec 2028
Last update posted: 3 Mar 2026
Registered enrollment: 440
Registry id: NCT06572384

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-513018-36-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.